Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Shanghai Aiyingshi Co.,Ltd (603214.SS)
Shanghai, ZJ, CN
Shanghai Aiyingshi Co.,Ltd provides maternal and child products and services primarily in China. The company’s products include infant dairy products, feeding supplies, toiletries, cotton textiles, paper products, toys, lathes, strollers, and other products. It also offers value-added services, such as childcare and early education, infant touch, parenting consultation, parent-child entertainment, and maternity and infant expo. It operates stores in Shanghai, Jiangsu, Zhejiang, Fujian, Guangdong, Chongqing, Hunan, Hubei, Jiangxi, and Sichuan. The company also sells its products through an online platform. Shanghai Aiyingshi Co.,Ltd was founded in 1997 and is headquartered in Shanghai, China.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2026-04 | Change |
|---|---|---|
| Strong Buy | 1 | -1 |
| Buy | 1 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Specialty Retail: +6.4%+8.8% ★ Q4'25: +5.3% (vs Q4'24)
-
EPS growth Specialty Retail: +20.6%-22.4% Q4'25: -50.0% (vs Q4'24)
-
FCF margin FCF growth · Specialty Retail: +29.3%+7.4% ★ Q4'25: +15.4% (vs Q4'24)
-
EBIT margin Specialty Retail: +5.4%+3.4% Q4'25: +4.5% (vs Q4'24)
-
ROIC Specialty Retail: +6.5%+7.9% ★ Q4'25: +10.4% (vs Q4'24)
-
Share dilution Specialty Retail: +0.1%-0.5% ★ Q4'25: -0.4% (vs Q4'24)
-
Debt / EBITDA Net debt/EBITDA · Specialty Retail: 0.14×1.49× ★ Q4'25: 1.27× (vs Q4'24)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 2 Rev. Ana. 2 EPS Ana. |
Dec 2027 2 Rev. Ana. 2 EPS Ana. |
Dec 2028 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
2.46B
est: 2.54B (-3.3%)
|
2.26B
est: 2.38B (-5.0%)
|
2.65B
est: 2.35B (+12.8%)
|
3.62B
est: 3.62B (+0.0%)
|
3.33B
est: 3.52B (-5.4%)
|
3.47B
est: 3.46B (+0.3%)
|
3.77B
est: 3.82B (-1.2%)
|
4.05B
3.99B – 4.11B
+6.0% YoY
|
4.38B
4.26B – 4.51B
+8.3% YoY
|
4.72B
4.62B – 4.83B
+7.8% YoY
|
| EBITDA |
246.90M
est: 295.10M (-16.3%)
|
194.94M
est: 275.52M (-29.2%)
|
171.05M
est: 272.62M (-37.3%)
|
202.30M
est: 419.65M (-51.8%)
|
207.65M
est: 408.29M (-49.1%)
|
195.28M
est: 225.01M (-13.2%)
|
324.99M
est: 248.50M (+30.8%)
|
263.47M
259.43M – 267.51M
+6.0% YoY
|
285.34M
276.97M – 293.71M
+8.3% YoY
|
307.47M
300.49M – 314.45M
+7.8% YoY
|
| EBIT |
230.29M
est: 148.14M (+55.5%)
|
175.17M
est: 138.31M (+26.7%)
|
148.30M
est: 136.86M (+8.4%)
|
167.13M
est: 210.67M (-20.7%)
|
177.75M
est: 204.96M (-13.3%)
|
178.75M
est: 196.80M (-9.2%)
|
127.98M
est: 217.34M (-41.1%)
|
230.44M
226.90M – 233.97M
+6.0% YoY
|
249.56M
242.25M – 256.88M
+8.3% YoY
|
268.92M
262.82M – 275.02M
+7.8% YoY
|
| Net Income |
154.25M
est: 151.79M (+1.6%)
|
116.57M
est: 130.82M (-10.9%)
|
73.48M
est: 80.72M (-9.0%)
|
85.95M
est: 84.89M (+1.2%)
|
104.72M
est: 115.51M (-9.3%)
|
106.41M
est: 110.72M (-3.9%)
|
81.46M
est: 143.34M (-43.2%)
|
140.56M
135.75M – 145.36M
-1.9% YoY
|
171.17M
165.15M – 177.20M
+21.8% YoY
|
203.18M
197.19M – 209.18M
+18.7% YoY
|
| SGA |
569.67M
est: 391.33M (+45.6%)
|
563.24M
est: 365.36M (+54.2%)
|
679.77M
est: 361.51M (+88.0%)
|
872.59M
est: 556.49M (+56.8%)
|
796.93M
est: 541.42M (+47.2%)
|
779.50M
est: 837.33M (-6.9%)
|
781.19M
est: 924.75M (-15.5%)
|
980.46M
965.43M – 995.49M
+6.0% YoY
|
1.06B
1.03B – 1.09B
+8.3% YoY
|
1.14B
1.12B – 1.17B
+7.8% YoY
|
| EPS |
1.10
est: 1.09 (+0.9%)
|
0.83
est: 0.94 (-11.7%)
|
0.52
est: 0.58 (-10.3%)
|
0.61
est: 0.61 (+0.0%)
|
0.75
est: 0.83 (-9.6%)
|
0.76
est: 0.81 (-6.4%)
|
0.59
est: 1.03 (-42.7%)
|
1.01
0.98 – 1.04
-1.9% YoY
|
1.23
1.19 – 1.27
+21.8% YoY
|
1.46
1.42 – 1.50
+18.7% YoY
|
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Lan Sun | Accounting Supervisor | — | — |
| Min Gao | Senior Vice President & Board Secretary | — | female |
| Qiong Shi | Chairman, President & Chief Executive Officer | — | male |
| Ruiqiang Mo | Vice President & Director | — | male |
| Xiao Si Wang | Vice President | — | female |
| Yeting Gong | Vice President of Finance | — | female |
| Yun Wang | Senior VP & Director | — | female |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 603214.SS
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
